The core therapeutic synergy arises from artemether's disruption of the ROS-NF-κB positive feedback loop, which inhibits neutrophil infiltration and lipid peroxidation, thereby ameliorating tissue injury in experimental models of arthritis and neurodegenerative diseases. This evidence concerns the gene NFKB1 and Arthritis.